The Company’s Board of Directors nominated Yun Yen to serve as the Chairman of the Board

1.Date of the board of directors resolution or date of occurrence of the change: 2023/06/27 2.Position (Please enter chairperson or president/general manager): Chairman 3.Name of the previous position holder: Yun …

Announcement that the institutional director of OBI, Sheng Cheng Investment Co., Ltd., changes its representative

1.Date of occurrence of the change: 2023/06/27 2.Name of legal person: Sheng Cheng Investment Co., Ltd. 3.Name of the previous position holder: Yun Yen 4.Resume of the previous position holder: …

Announcement of 2023 shareholders’ meeting’s resolution to lift the non-competition restrictions for directors

1.Date of the shareholders’ meeting resolution: 2023/06/27 2.Name and title of the managerial officer with permission to engage in competitive conduct: Director Yun Yen 3.Items of competitive conduct in which …

Announcement of the Company’s important resolutions of the 2023 annual shareholders’ meeting

1.Date of the shareholders’ meeting:2023/06/27 2.Important resolutions I. Profit distribution/deficit compensation: Acknowledgement of the 2022 Earning Distribution Loss Off-setting. 3.Important resolutions II. Amendments of the company charter: Resolution of amendment …

Announcement of By-election of the director at the 2023 Annual Shareholders’ Meeting

1.Date of occurrence of the change:2023/06/27 2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor): Natural-person director 3.Title and name of the …

Announcement on behalf of Amaran of important resolutions of the 2023 annual shareholders’ meeting

1.Date of the shareholders’ meeting: 2023/06/20 2.Important resolutions I. Profit distribution/deficit compensation: Acknowledgement of the 2022 Earning Distribution Loss Off-setting. 3.Important resolutions II. Amendments of the company charter: Resolution of …

Announcement on behalf of Obigen’s resolution to lift the non-competition restrictions for directors at 2023 annual shareholders’ meeting

1.Date of the shareholders’ meeting resolution:2023/06/16 2.Name and title of the managerial officer with permission to engage in competitive conduct: Director Frank Chen, Representative of OBI Pharma, Inc. Director Chung …

Announcement on behalf of Obigen of important resolutions of the 2023 annual shareholders’ meeting

1.Date of the shareholders’ meeting:2023/06/16 2.Important resolutions I. Profit distribution/deficit compensation: Acknowledgement of the 2022 Earning Distribution Loss Off-setting. 3.Important resolutions II. Amendments of the company charter: None 4.Important resolutions …

The COVID-19 vaccine, BCVax, has been granted by TFDA to proceed to Phase I clinical trial

1.Date of occurrence of the event:2023/06/02 2.New drug name or code:COVID-19 vaccine, BCVax 3.Indication: COVID-19 vaccine, BCVax, is composed of the Delta spike protein with nanoparticle saponins as adjuvant that …

OBI Pharma Announces Executive Leadership Management Change – Heidi Wang, Ph.D. appointed as Chief Executive Officer

Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision to bring innovative cancer therapies to patients globally. She …